Elekta AB (publ) (EKTA-B.ST)
SEK 61.7
(2.32%)
SEK 61.7
(2.32%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 3.25 Billion SEK | 6.16% |
| 2022 | 3.07 Billion SEK | 21.25% |
| 2021 | 2.53 Billion SEK | 10.91% |
| 2020 | 2.28 Billion SEK | -16.92% |
| 2019 | 2.74 Billion SEK | 4.33% |
| 2018 | 2.63 Billion SEK | 135.18% |
| 2017 | 1.12 Billion SEK | 19.66% |
| 2016 | 936 Million SEK | -17.53% |
| 2015 | 1.13 Billion SEK | -12.49% |
| 2014 | 1.29 Billion SEK | 20.32% |
| 2013 | 1.07 Billion SEK | 26.82% |
| 2012 | 850 Million SEK | 12.58% |
| 2011 | 755 Million SEK | 39.81% |
| 2010 | 540 Million SEK | -8.78% |
| 2009 | 592 Million SEK | 7.05% |
| 2008 | 553 Million SEK | 4.54% |
| 2007 | 529 Million SEK | 25.06% |
| 2006 | 423 Million SEK | 16.21% |
| 2005 | 364 Million SEK | 0.55% |
| 2004 | 362 Million SEK | 16.4% |
| 2003 | 311 Million SEK | 20.54% |
| 2002 | 258 Million SEK | -4.09% |
| 2001 | 269 Million SEK | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 3.52 Billion SEK | 8.13% |
| 2023 FY | 3.25 Billion SEK | 6.16% |
| 2023 Q3 | 3.53 Billion SEK | -7.04% |
| 2023 Q4 | 3.25 Billion SEK | -7.89% |
| 2023 Q1 | 3.73 Billion SEK | 21.56% |
| 2023 Q2 | 3.8 Billion SEK | 1.98% |
| 2022 Q2 | 3.21 Billion SEK | 7.56% |
| 2022 Q3 | 3.33 Billion SEK | 3.76% |
| 2022 FY | 3.07 Billion SEK | 21.25% |
| 2022 Q1 | 2.99 Billion SEK | 18.09% |
| 2022 Q4 | 3.07 Billion SEK | -8.0% |
| 2021 Q3 | 2.74 Billion SEK | 13.53% |
| 2021 Q4 | 2.53 Billion SEK | -7.69% |
| 2021 FY | 2.53 Billion SEK | 10.91% |
| 2021 Q2 | 2.41 Billion SEK | -2.85% |
| 2021 Q1 | 2.48 Billion SEK | 8.94% |
| 2020 Q4 | 2.28 Billion SEK | -5.5% |
| 2020 Q2 | 2.45 Billion SEK | -2.42% |
| 2020 FY | 2.28 Billion SEK | -16.92% |
| 2020 Q1 | 2.51 Billion SEK | -8.44% |
| 2020 Q3 | 2.41 Billion SEK | -1.59% |
| 2019 Q1 | 2.78 Billion SEK | 5.54% |
| 2019 FY | 2.74 Billion SEK | 4.33% |
| 2019 Q2 | 3.04 Billion SEK | 9.64% |
| 2019 Q3 | 2.95 Billion SEK | -2.92% |
| 2019 Q4 | 2.74 Billion SEK | -7.13% |
| 2018 Q4 | 2.63 Billion SEK | 5.02% |
| 2018 FY | 2.63 Billion SEK | 135.18% |
| 2018 Q3 | 2.5 Billion SEK | 1.83% |
| 2018 Q2 | 2.46 Billion SEK | -0.89% |
| 2018 Q1 | 2.48 Billion SEK | 121.88% |
| 2017 Q1 | 1.07 Billion SEK | 14.96% |
| 2017 Q4 | 1.12 Billion SEK | -9.9% |
| 2017 FY | 1.12 Billion SEK | 19.66% |
| 2017 Q3 | 1.24 Billion SEK | 12.79% |
| 2017 Q2 | 1.1 Billion SEK | 2.42% |
| 2016 Q4 | 936 Million SEK | -24.76% |
| 2016 Q2 | 1.25 Billion SEK | 5.53% |
| 2016 Q3 | 1.24 Billion SEK | -1.19% |
| 2016 FY | 936 Million SEK | -17.53% |
| 2016 Q1 | 1.19 Billion SEK | 5.11% |
| 2015 Q1 | 1.48 Billion SEK | 14.11% |
| 2015 Q3 | 1.46 Billion SEK | 3.18% |
| 2015 FY | 1.13 Billion SEK | -12.49% |
| 2015 Q2 | 1.41 Billion SEK | -4.26% |
| 2015 Q4 | 1.13 Billion SEK | -22.37% |
| 2014 Q1 | 1.28 Billion SEK | 18.74% |
| 2014 Q4 | 1.29 Billion SEK | -10.3% |
| 2014 Q3 | 1.44 Billion SEK | 10.05% |
| 2014 FY | 1.29 Billion SEK | 20.32% |
| 2014 Q2 | 1.31 Billion SEK | 2.66% |
| 2013 Q1 | 1 Billion SEK | 17.65% |
| 2013 Q3 | 1.36 Billion SEK | 24.7% |
| 2013 Q2 | 1.09 Billion SEK | 9.7% |
| 2013 Q4 | 1.07 Billion SEK | -21.2% |
| 2013 FY | 1.07 Billion SEK | 26.82% |
| 2012 FY | 850 Million SEK | 12.58% |
| 2012 Q4 | 850 Million SEK | -9.57% |
| 2012 Q3 | 940 Million SEK | 2.62% |
| 2012 Q2 | 916 Million SEK | -0.11% |
| 2012 Q1 | 917 Million SEK | 21.46% |
| 2011 Q1 | 638 Million SEK | 18.15% |
| 2011 Q4 | 755 Million SEK | -10.76% |
| 2011 Q3 | 846 Million SEK | 10.88% |
| 2011 FY | 755 Million SEK | 39.81% |
| 2011 Q2 | 763 Million SEK | 19.59% |
| 2010 Q1 | 646 Million SEK | 9.12% |
| 2010 FY | 540 Million SEK | -8.78% |
| 2010 Q3 | 646 Million SEK | 6.78% |
| 2010 Q4 | 540 Million SEK | -16.41% |
| 2010 Q2 | 605 Million SEK | -6.35% |
| 2009 Q4 | 592 Million SEK | 0.0% |
| 2009 FY | 592 Million SEK | 7.05% |
| 2008 FY | 553 Million SEK | 4.54% |
| 2007 FY | 529 Million SEK | 25.06% |
| 2006 FY | 423 Million SEK | 16.21% |
| 2005 FY | 364 Million SEK | 0.55% |
| 2004 FY | 362 Million SEK | 16.4% |
| 2003 FY | 311 Million SEK | 20.54% |
| 2002 FY | 258 Million SEK | -4.09% |
| 2001 FY | 269 Million SEK | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| AddLife AB (publ) | 1.65 Billion SEK | -97.157% |
| Biotage AB (publ) | 437 Million SEK | -645.767% |
| Bonesupport Holding AB (publ) | 83.3 Million SEK | -3812.177% |
| Doxa AB (publ) | - SEK | -Infinity% |
| iZafe Group AB (publ) | 4.05 Million SEK | -80329.437% |
| Ortivus AB (publ) | 12.45 Million SEK | -26057.798% |
| Ortivus AB (publ) | 12.45 Million SEK | -26057.798% |
| Q-linea AB (publ) | 46.52 Million SEK | -6904.535% |
| S2Medical AB (publ) | 4.09 Million SEK | -79393.408% |
| Synsam AB (publ) | 707 Million SEK | -360.962% |